Whole Body Periodic Acceleration: "Passive Exercise" for Parkinson’s disease

Whole Body Periodic Acceleration: "Passive Exercise" for Parkinson’s disease Review (733) Total Article Views Authors: Sackner MA Published Date April 2012 Volume 2012:2 Pages 1 - 5 DOI: http://dx.doi.org/10.2147/JPRLS.S37048 Received: 15 August 2012 Accepted: Published: 17 August 2012 Marvin A. Sackner Voluntary Professor of Medicine at Mt Sinai, Miller School of Medicine, University of Miami and Emeritus Director of Medical Services, Mt Sinai Medical Center of Greater Miami The important benefits of exercise in the prevention and treatment of chronic diseases have long been recognized. However, exercise participation such as brisk walking at least 30 minutes a day for five days a week as recommended by the American Heart Association is accomplished in less than 10% of the adult American population.1 For patients with chronic conditions such as Parkinson’s disease (PD), compliance is even lower. Patients with PD are usually elderly, often sedentary, and frail, with the afflictions of cardio-vascular and rheumatologic diseases and therefore incapable of exercising. Further, the fear of falling, freezing of gait, and impaired economy of gait (small stepping distance) associated with PD interfere with walking.2 3 4 Therefore, there is a place for technology that would provide similar benefits to exercise without requiring voluntary movements. Post to: Cannotea Citeulike Del.icio.us Facebook LinkedIn Twitter Readers of this article also read: Imaging of peripheral vascular disease Fructose-enhanced reduction of bacterial growth on nanorough surfaces Synthesis, characterization, and in vivo efficacy evaluation of PGG–docetaxel conjugate for potential cancer chemotherapy Enhancing the specificity and efficiency of polymerase chain reaction using polyethyleneimine-based derivatives and hybrid nanocomposites In vitro and in vivo studies on gelatin-siloxane nanoparticles conjugated with SynB peptide to increase drug delivery to the brain Improved oral bioavailability of poorly water-soluble indirubin by a supersaturatable self-microemulsifying drug delivery system Insight into 144 patients with ocular vascular events during VEGF antagonist injections Efficacy of ipamorelin, a ghrelin mimetic, on gastric dysmotility in a rodent model of postoperative ileus Allergic bronchopulmonary aspergillosis treated successfully for one year with omalizumab Dexmedetomidine sedation in painful posterior segment surgery